美股A股
StockGist
Back
8-K2026-03-12· grok-4-1-fast-non-reasoning

XENE · Xenon Pharmaceuticals Inc.

0001193125-26-104199

SEC filing

Summary

Xenon Pharmaceuticals Inc. entered into an Underwriting Agreement on March 10, 2026. The Company filed an 8-K on March 12, 2026, including the Underwriting Agreement as Exhibit 1.1.

Key takeaways